Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000493:pharmacokinetics*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006321:Heart / Q000187:drug effects; D006801:Humans; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D009206:Myocardium; D009369:Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
D043823:Taxoids; C426424:7-methylthiomethylpaclitaxel; D004317:Doxorubicin